Scarica l'app Stockscreener
1.10
0.00%
0.00
Dopo l'orario di chiusura:
1.76
0.66
+60.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.10
Aprire:
$1.09
Volume 24 ore:
79,661
Relative Volume:
0.14
Capitalizzazione di mercato:
$16.65M
Reddito:
$3,000
Utile/perdita netta:
$-7.78M
Rapporto P/E:
-1.0632
EPS:
-1.0346
Flusso di cassa netto:
$-7.49M
1 W Prestazione:
+0.92%
1M Prestazione:
+13.75%
6M Prestazione:
-13.39%
1 anno Prestazione:
-48.11%
Intervallo 1D:
$1.07
$1.105
Intervallo di 1 settimana:
$1.06
$1.14
Portata 52W:
$0.75
$2.29
Biocardia Inc Stock (BCDA) Company Profile
Nome
Biocardia Inc
Settore
Industria
Telefono
650-226-0123
Indirizzo
320 SOQUEL WAY, SUNNYVALE, CA
Compare BCDA vs MOBBW, PSNYW, GOODO, SHMD, CHAD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.41 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.395 | 1.79B | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
4.14 | 698.19M | 2.07B | -1.42B | -1.37B | -0.6765 |
GOODO
Gladstone Commercial Corporation
|
19.67 | 372.90M | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
3.23 | 226.24M | 52.15M | -21.46M | 0 | -0.4675 |
CHAD
Direxion Daily CSI 300 China A
|
8.07 | 197.39M | 0 | 0 | 0 | 0.00 |
Biocardia Inc Stock (BCDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-04-16 | Downgrade | Dawson James | Buy → Neutral |
Biocardia Inc Borsa (BCDA) Ultime notizie
Form 8K Biocardia Inc For: 10 September By Investing.com - Investing.com Canada
BioCardia to present CardiAMP regulatory progress, Helix and Heart3D updates at H.C. Wainwright - TradingView
BioCardia to Present CardiAMP, Helix and Heart3D Progress at H.C. Wainwright Global Investment Conference - Quiver Quantitative
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times
A heart-failure cell therapy could reach Japanese regulators by year-end. BioCardia is preparing the filing. - Stock Titan
Why Did BCDA Stock Surge More Than 50% Today? - Stocktwits
BioCardia CEO Peter Altman buys 800 shares for $872 - Bitget
BioCardia CEO Peter Altman buys $872 in company stock By Investing.com - Investing.com Nigeria
BioCardia CEO Peter Altman buys $872 in company stock - Investing.com
BioCardia (BCDA) CEO adds 800 shares in open-market buy - Stock Titan
BioCardia Inc. Warrant (BCDAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
BioCardia (BCDA) Session: Finishes 4.95% Higher at $1.06 at the Close; Price Setup: Price Remains Between $1.01 Support and $1.11 Resistance on the DaySmart Beta Flow - vinanet.vn
BioCardia receives FDA confirmation on Helix catheter meeting By Investing.com - Investing.com Nigeria
BioCardia Advances Helix Catheter Toward De Novo Approval - TipRanks
BioCardia Receives Nasdaq Notice on Minimum Bid Price - The Globe and Mail
BioCardia Received Notice of Noncompliance - TradingView
BioCardia’s Q2 2026 Update Keeps the Regulatory Story Alive, but Capital Still Drives the Risk - AlphaStreet
BioCardia CEO Peter Altman acquires 5,400 common shares worth $5,022 - Bitget
BioCardia CEO Peter Altman buys $5,022 in company stock - Investing.com
BioCardia (BCDA) CEO buys 5,400 shares in open market - Stock Titan
BCDA Q2 2026 Earnings: EPS Surprise of 29.19% Narrows Losses as Shares Climb 4.82%Estimate Revision Count - vinanet.vn
BioCardia (BCDA) Pushes Higher: Micro-Cap Biotech Gains 4.8% as It Nears $1.02 ResistanceIceberg Order - vinanet.vn
BCDA Q2 2026 Earnings: Narrower-than-Expected Loss Drives Shares Up 4.82%Earnings Revision Upgrade - vinanet.vn
BioCardia CEO Peter Altman buys $1,748 in company stock By Investing.com - Investing.com Canada
BioCardia CEO Peter Altman buys $1,748 in company stock - Investing.com
BioCardia (BCDA) CEO Peter Altman purchases 1,900 shares at $0.92 average price - Stock Titan
BioCardia (BCDA) Holds at $0.88 as Range-Bound Trading PersistsTriple Top - vinanet.vn
BioCardia (BCDA) Drops 5.6% to $0.88 as Micro-Cap Biotech Tests Support LevelInsider Buying Alerts - vinanet.vn
BioCardia (BCDA) Advances Regulatory Pathway, Faces High Price-t - GuruFocus
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ... - Yahoo! Finance Canada
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulat - GuruFocus
BioCardia, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
BioCardia Q2 loss narrows 67.5% YoY; regulatory milestones advance - scanx.trade
BCDA: Regulatory milestones and strong cash position support major market entry for cardiac therapies - TradingView
Earnings call transcript: BioCardia posts q2 2026 loss beat, shares rise after hours - Investing.com
Is BioCardia Inc (BCDA) Facing Financial Challenges After Q2 Ear - GuruFocus
BioCardia reports Q2 2026 net loss narrows to $1.6M; cash $4.1M with runway into 2027 - TradingView
BioCardia Reports Q2 2026 Net Loss of $1.6 Million - Quiver Quantitative
BioCardia (BCDA) Q2 2026 Earnings Call Transcript - The Globe and Mail
BCDA: Regulatory progress, clinical advances, and improved financials position for late 2026 submissions - TradingView
BioCardia, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results - The Manila Times
BRIEF-BioCardia, Inc. Q2 Net Income USD -1.613 Million - tradingview.com
BioCardia (BCDA.US) will release its earnings report before market open on August 12. - Moomoo
BioCardia Inc (BCDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioCardia, Inc. Revenue Breakdown – NASDAQ:BCDA - TradingView
BioCardia Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView
BioCardia Inc (BCDA) Stock News Today - TradingKey
Insiders In BioCardia Still Down 21% On US$1.08m Investment - simplywall.st
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026 - The Manila Times
BioCardia to Report Second Quarter 2026 Financial Results and Provide Corporate Update on August 12 Conference Call - Quiver Quantitative
Biocardia Inc Azioni (BCDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):